Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |